Abstract: The invention relates to a pharmaceutical composition comprising Factor VIIa for subcutan, intramuscular or interdermal administration.
Factor VIIa administered subcutanously, intramuscularly or intradermally shows a sufficient transport into the bloodstream in biologically active form and in adequate concentrations, and favorable pharmacokinetic properties.
Type:
Grant
Filed:
October 25, 2001
Date of Patent:
December 21, 2004
Assignee:
Novo Nordisk Pharmaceuticals, Inc.
Inventors:
Marie Johannessen, Ole Juul Nordfang, Jens Aas Jansen